Jain, GauravMore, Balaji D.2020-04-092020-04-092020-01Jain Gaurav, More Balaji D.. Prevalence of metabolic syndrome and its different components in patients with acute coronary syndrome. International Journal of Advances in Medicine. 2020 Jan; 7(1): 168-1712349-39252349-3933http://imsear.searo.who.int/handle/123456789/194557Background: Several components of the Metabolic Syndrome (MetS) are risk factor for cardiovascular diseases. So, this study was conducted to evaluate the prevalence of MetS and its components in patients with CAD.Methods: Author included all patients admitted with Acute Coronary Syndrome (ACS), who had CAD confirmed by coronary angiography. They were divided into two groups according to presence or absence of MetS based on International Diabetes Federation criteria. The prevalence of MetS and its individual components was estimated.Results: It was observed that there is a high prevalence of MetS (66%) in patients admitted with ACS. Metabolic syndrome is more prevalent in female patients (82.4%) than in male patients (57.6%) with ACS. Hypertension is the most prevalent (87.9) component of MetS. Diabetes Mellitus (DM) is the 2nd most prevalent (83.3%) component of MetS. About 65.2% patients with MetS had abnormally raised triglyceride levels and 32(48.5%) had abnormally low HDL-cholesterol level. Among the MetS 38(57.6%) had abnormal waist circumference. Among the study group, the most common triad of MetS components was DM + HTN + abnormal TG. There is significant association between MetS and microalbuminuria, with incidence of 22(33.3%) in this study. Similarly, a significant association between DM and microalbuminuria, 23(33.8%) was observed.Conclusions: This study confirms a very high prevalence of MetS in Indian patients with CAD. The prevalence of the risk factors was higher in CAD patients with MetS.Coronary artery diseaseDiabetes mellitusHypertensionMetabolic syndromePrevalenceTriglyceridesJournal ArticleIndiaStudent, SS Institute of Medical Sciences, Davangere, Karnataka, IndiaDepartment of Pharmacology, Pacific Institute of Medical Sciences, Udaipur, Rajasthan, India